Invesco Ltd. (IVZ)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9, Altman Z 1.0. DCF fair value of $82 implies 236% upside from current prices based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Invesco Ltd. present a stark divergence between top-line expansion and bottom-line erosion, characterized by a negative ROIC-WACC spread of -10.5% that signals value destruction relative to the cost of capital. While revenue grew 5.1% year-over-year with healthy gross margins at 35.2%, this growth is being consumed entirely by operating inefficiencies, resulting in a net margin contraction to -4.4%. This profitability weakness drives the DuPont ROE decomposition into negative territory (-2.2%), where low asset turnover (0.24x) and modest leverage fail to offset the loss-making core business. Despite these operational headwinds, qualitative risk metrics remain mixed; the company maintains a robust Beneish M-Score of -2.87 suggesting low earnings manipulation risk, yet its Altman Z-Score of 1.0 indicates elevated bankruptcy distress probability, while the Piotroski F-Score of 6/9 suggests underlying financial strength has not fully deteriorated despite recent profit declines.
Valuation metrics reveal a significant disconnect between current market pricing and model-derived fair value estimates. The stock trades at a substantial discount to its DCF-implied fair value of $82, which translates to an apparent upside potential exceeding 238%, even as the implied free cash flow growth assumption remains conservative at just 2.3% over ten years. This wide gap suggests the market is heavily penalizing the current negative net margins and weak profitability factor score (RMW: -0.193) without fully incorporating the long-term value potential indicated by the model, particularly given that the sector average P/E of 18.3x assumes normalized earnings rather than the current loss-making reality.
From a risk-adjusted return perspective, Invesco exhibits an anomalous Fama-French alpha of 21.09% and a strong value tilt (HML: 0.805), implying it has historically outperformed its factor benchmarks despite deteriorating fundamental quality. Neutral insider flow over the past ninety days offers no directional signal from management, leaving the investment thesis reliant on whether the market will re-rate the stock based on future margin stabilization or if the high distress score and negative spread will persist as a structural drag. The convergence of weak profitability metrics with an ostensibly attractive valuation gap creates a scenario where downside protection is thin while upside relies entirely on a fundamental turnaround.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 5% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 7.7% | 9.7% | 11.7% |
|---|---|---|---|
| 2% | $104 | $71 | $52 |
| 3% | $125 | $82 | $58 |
| 4% | $159 | $96 | $66 |
Center = base case. Green = >10% upside, Red = >10% downside vs $27.58.
Pre-computed DCF: WACC=9.7%, terminal growth 3%. Fair value $82 (+235.8%). Not investment advice.
Price Chart with Moving Averages
Technical Setup
AI GeneratedThe current technical configuration for Invesco Ltd. presents a complex landscape regarding institutional positioning, characterized by conflicting signals between price action and volume dynamics. While the stock trades at $27.05 within the Financial Services sector, the absence of specific moving average crossover data or explicit volume trends in the provided dataset prevents a definitive conclusion on whether larger market participants are accumulating or distributing shares. Typically, sustained upward momentum accompanied by rising volume would suggest institutional accumulation, whereas declining price amidst shrinking volume might indicate a lack of support from major holders. Without these critical metrics, it remains unclear if the current price level represents a zone where significant capital is entering the position or if institutions are quietly reducing exposure. The limited data available does not reveal whether key moving averages have recently crossed to signal a trend reversal or continuation, which are often primary tools used by fund managers to gauge market direction. Similarly, without observing volume spikes during specific price movements, one cannot determine if recent trading activity reflects genuine institutional interest or merely retail participation. This ambiguity leaves the precise sentiment of large players undefined; they could be waiting for clearer technical confirmations before committing substantial capital, or they may have already adjusted their holdings based on factors not captured in this snapshot. Consequently, any assessment of whether the stock is currently undervalued from an institutional perspective relies entirely on external context rather than the intrinsic signals present here.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-05-15 | $0.2150 | +2.4% |
| 2026-02-13 | $0.2100 | 0.0% |
| 2025-11-14 | $0.2100 | 0.0% |
| 2025-08-14 | $0.2100 | 0.0% |
| 2025-05-14 | $0.2100 | +2.4% |
| 2025-02-14 | $0.2050 | 0.0% |
| 2024-11-14 | $0.2050 | 0.0% |
| 2024-08-16 | $0.2050 | 0.0% |
| 2024-05-13 | $0.2050 | +2.5% |
| 2024-02-15 | $0.2000 | 0.0% |
| 2023-11-09 | $0.2000 | 0.0% |
| 2023-08-10 | $0.2000 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like DVY or ONEY, the fund manager is mechanically forced to buy or sell IVZ shares regardless of Invesco Ltd.'s individual fundamentals. We estimate $1.3B of passive capital is structurally linked to IVZ through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Invesco Ltd. to visualize passive redemption contagion across ETFs and collateral stocks.
If Invesco Ltd. (IVZ) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies BERKSHIRE HATHAWAY INC CL B (BRK.B) as the most exposed collateral stock, sharing 1 ETFs with IVZ. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 16 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
IVZ Ownership Dynamics
Passive funds hold 1 in every 9 IVZ shares, reducing daily market volatility.
Invesco Ltd. (IVZ) exerts measurable gravity on the passive index market, currently representing 1.2% of the iShares Select Dividend ETF (DVY) and 0.3% of the ONEY (ONEY). Across 16 tracked ETFs, approximately 49M shares (11.1% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest IVZ Exposure
Float lock-up computed from 16 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
IVZ Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Invesco Ltd. over the past year sits near $23.52 (11% of 252-day volume). The current price of $27.58 trades 17.3% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-04-15 | 6 | $24.72 | $148.32 |
| 2026-04-06 | 2,641 | $24.14 | $63,753.74 |
| 2026-04-02 | 3,764 | $24.32 | $91,540.48 |
| 2026-03-31 | 367 | $23.29 | $8,547.43 |
| 2026-03-25 | 44 | $23.98 | $1,055.12 |
| 2026-03-18 | 1,561 | $23.73 | $37,042.53 |
| 2026-03-13 | 1,579 | $22.90 | $36,159.1 |
| 2026-03-02 | 602 | $26.26 | $15,808.52 |
| 2026-02-17 | 74 | $26.52 | $1,962.48 |
| 2026-02-05 | 344,720 | $26.84 | $9.3M |
| 2026-02-04 | 347,803 | $26.53 | $9.2M |
| 2026-01-23 | 10,875 | $29.24 | $317,985 |
| 2026-01-22 | 10,845 | $29.17 | $316,348.65 |
| 2026-01-21 | 12,656 | $27.91 | $353,228.96 |
| 2026-01-20 | 16,342 | $29.44 | $481,108.48 |
| 2025-12-26 | 434 | $27.21 | $11,809.14 |
| 2025-12-23 | 38,769 | $27.34 | $1.1M |
| 2025-12-22 | 27 | $27.00 | $729 |
| 2025-12-11 | 17 | $26.93 | $457.81 |
| 2025-12-05 | 155 | $25.21 | $3,907.55 |
| 2025-12-02 | 5,308 | $24.66 | $130,895.28 |
| 2025-11-14 | 17 | $23.98 | $407.66 |
| 2025-11-04 | 118,449 | $23.58 | $2.8M |
| 2025-11-03 | 62 | $23.70 | $1,469.4 |
| 2025-10-20 | 337 | $22.79 | $7,680.23 |
| 2025-10-16 | 25 | $23.60 | $590 |
| 2025-10-15 | 792 | $23.45 | $18,572.4 |
| 2025-10-03 | 200 | $23.61 | $4,722 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| RF | 0.665 | 0.538 | Moderate |
| BLK | 0.656 | 0.710 | Moderate |
| STT | 0.654 | 0.679 | Moderate |
| TROW | 0.643 | 0.704 | Moderate |
| MC | 0.632 | 0.722 | Moderate |
| BEN | 0.631 | 0.668 | Moderate |
| KEY | 0.627 | 0.605 | Moderate |
| MS | 0.625 | 0.671 | Moderate |
| GS | 0.622 | 0.655 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare IVZ to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.